Benzinga | Aug 17, 2020 08:36AM EDT

DelMar Announces Approval Of Merger By Stockholders

SAN DIEGO, Aug. 17, 2020 /PRNewswire/ --DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) ("DelMar" or the "Company") announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar's stockholders at a special meeting held on August 14, 2020. The holders of a majority of the outstanding shares of common stock of Adgero have also issued their written consent approving the merger. The proposed merger remains subject to further customary closing conditions. DelMar expects the closing of the merger to occur in August 2020.